# Effect of a Combination of Hyaluronic Acid, Chondroitin Sulphate and Magnesium Trisilicate on Subjects With GastroEsophageal Reflux Disease

> **NCT03883074** · NA · COMPLETED · sponsor: **SOFAR S.p.A.** · enrollment: 21 (actual)

## Conditions studied

- Gastro Esophageal Reflux

## Interventions

- **DEVICE:** hyaluronic acid with chondroitin + sulphate + magnesium trisilicate
- **DEVICE:** Placebo

## Key facts

- **NCT ID:** NCT03883074
- **Lead sponsor:** SOFAR S.p.A.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-12-20
- **Primary completion:** 2021-09-16
- **Final completion:** 2021-09-16
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2022-05-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03883074

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03883074, "Effect of a Combination of Hyaluronic Acid, Chondroitin Sulphate and Magnesium Trisilicate on Subjects With GastroEsophageal Reflux Disease". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03883074. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*